Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · IEX Real-Time Price · USD
0.596
-0.021 (-3.34%)
At close: Jul 19, 2024, 4:00 PM
0.597
+0.001 (0.18%)
Pre-market: Jul 22, 2024, 7:47 AM EDT
Bionano Genomics Revenue
Bionano Genomics had revenue of $37.47M in the twelve months ending March 31, 2024, with 26.93% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $8.77M with 18.26% year-over-year growth. In the year 2023, Bionano Genomics had annual revenue of $36.12M with 29.90% growth.
Revenue (ttm)
$37.47M
Revenue Growth
+26.93%
P/S Ratio
1.28
Revenue / Employee
$108,924
Employees
344
Market Cap
48.13M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 36.12M | 8.31M | 29.90% |
Dec 31, 2022 | 27.80M | 9.82M | 54.62% |
Dec 31, 2021 | 17.98M | 9.48M | 111.47% |
Dec 31, 2020 | 8.50M | -1.63M | -16.06% |
Dec 31, 2019 | 10.13M | -1.87M | -15.59% |
Dec 31, 2018 | 12.00M | 2.50M | 26.26% |
Dec 31, 2017 | 9.51M | 2.71M | 39.93% |
Dec 31, 2016 | 6.79M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBNGO News
- 13 days ago - Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 17 days ago - Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 20 days ago - Scientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations - GlobeNewsWire
- 4 weeks ago - Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research - GlobeNewsWire
- 4 weeks ago - Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis - GlobeNewsWire
- 2 months ago - Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress - GlobeNewsWire
- 3 months ago - Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing - GlobeNewsWire
- 3 months ago - Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire